Treatment of Myelodysplastic Syndrome (MDS) With Cytokine-Immunotherapy for Low-Risk MDS.
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Ciclosporin; Erythropoietin; Granulocyte colony stimulating factor stimulants; Prednisone
- Indications Myelodysplastic syndromes
- Focus Therapeutic Use
- 07 Aug 2012 Biomarkers information updated
- 13 Apr 2011 Status changed from discontinued to completed as reported by ClinicalTrials.gov.
- 12 Mar 2010 Actual patient number (15) added as reported by ClinicalTrials.gov.